Open AccessEffectiveness comparisons of Chinese patent medicine on insomnia
Author(s) -
Hongqiang An,
Bing Li,
Jifeng Zhao,
Zhijian Ao,
Xiaohui Zhong,
Pengfei Zhu,
Jianlin Wu
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000024446
Subject(s) - medicine , cochrane library , insomnia , meta analysis , randomized controlled trial , primary insomnia , medline , physical therapy , psychiatry , sleep disorder , law , political science
Abstract Background: In recent years, the incidence of insomnia is increasing. However, the existing therapy methods for cannot fundamentally treat the disease. Meanwhile, Chinese patent medicine (CPM) plays an active role in the treatment of insomnia. However, there is no comparison and ranking of the efficacy of every CPM. Therefore, our study will use network meta-analysis to compare the efficacy of different CPM on insomnia, in order to provide evidence-based medical evidence for clinical treatment. Methods: We will search CNKI, Wanfang, VIP, CBM, Pubmed, Cochrane Library, Embase for the randomized controlled trials of CPM in the treatment of insomnia (up to December 31, 2020). We will use RevMan5.3, Stata15.1 and ADDIS software for statistical analysis. We will draw the surface under cumulative ranking area to predict the order of efficacy. Results: We aim to rank the efficacy and safety of different CPM for the treatment of insomnia. Conclusion: CPM plays a positive role in the treatment of insomnia and can provide evidence support for clinicians and patients INPLASY registration number: INPLASY2020120121